Events calendar
Please join us for a live webinar on the 20th May 15.00–16.00 at which Professor Axel Behrens (Cancer Research UK Convergence Science Centre Scientific Director) is pleased to host Professor Udai Banerji and Dr Emma Harris.
In this series of webinars brought to you by the Cancer Research UK Convergence Science Centre at Imperial College London and The Institute of Cancer Research, London, researchers across the two organisations will discuss key challenges facing cancer research and opportunities for new convergence science approaches to address these. Join us to consider how novel approaches and technologies could shed light on unresolved problems in cancer biology, to innovate new ways to address challenges in cancer and bring pioneering treatments to cancer patients faster.
In this talk Professor Banerji will discuss the use of microbubbles to increase drug concentrations in tumour, preclinical and clinical experience. Udai Banerji is the Deputy Director of the drug development unit at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. His clinical interests include hypothesis testing first in human studies, pharmacokinetics, pharmacodynamics and predictive biomarkers. Laboratory interests include drug resistance and clinical proteomics.
Disclaimer: he is not a West Ham fan!
Increased solid and fluid pressure in tumours impact negatively on patient prognosis and the efficacy of therapy. Vibrational shear wave elastography can be used to characterise the viscoelastic properties of tumours, which may aid both preclinical studies and clinical management of cancer treatments. In this talk Dr Harris will present advances in the development of ultrasound-based shear wave elastography for preclinical (in vivo) cancer research, and its potential as a clinical tool will be discussed.
Dr. Harris is a Reader of Imaging and Radiation Physics at The Institute of Cancer Research. She leads experimental and clinical studies of image guided radiotherapy and a programme of research developing preclinical ultrasound imaging technologies for the characterisation of tumour vasculature and stiffness as early indicators of tumour response to therapy.
To receive information about how to access this event please email icr-imperial-convergence.centre@imperial.ac.uk
Please note: This webinar is exclusively available only to colleagues across the Institute of Cancer Research, Imperial College London, the Royal Marsden Hospital and Imperial College Healthcare.